K-CAB insert

Category:

Description

K-Cab (tegoprazan), a treatment for gastroesophageal reflux disease (GERD), is more effective in reducing night-time gastric acid than not only an existing proton pump inhibitor (PPI) but another potassium-competitive acid blocker (P-CAB), a study said.